Cite Filings / CCCC / 0001628280-24-044613

Feed Companies Filings Check

Sign in

S-3

Registration Statement

C4 Therapeutics, Inc. Filed 2024-10-31 Acc 0001628280-24-044613

Documents 1

S-3 Registration Statement , s-3resale.htm

Around this filing

2025-11-21 S-3 Registration Statement
2024-10-31 S-3 Registration Statement
2024-10-31 S-3 Registration Statement
2024-10-31 10-Q Quarterly Report
2024-10-31 8-K Results of operations
2024-10-29 4 Chief Scientific Officer acquired 76,800 shares (grant or award)
2024-10-29 3 Initial Statement of Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading s-3resale.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…